+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pegaspargase"

Investigation Report on China's Pegaspargase Market, 2019-2023 - Product Thumbnail Image

Investigation Report on China's Pegaspargase Market, 2019-2023

  • Report
  • September 2019
  • 30 Pages
  • China
From
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Pegaspargase is a drug used to treat acute lymphoblastic leukemia (ALL). It is a form of chemotherapy that works by inhibiting the growth of cancer cells. It is typically used in combination with other drugs to treat ALL. Pegaspargase is a synthetic form of the enzyme asparaginase, which is naturally produced by the body to break down the amino acid asparagine. By inhibiting the production of asparagine, pegaspargase helps to reduce the amount of cancer cells in the body. Pegaspargase is used in combination with other drugs to treat ALL, and is often used in combination with other chemotherapy drugs, such as vincristine and prednisone. It is also used in combination with other drugs to treat other types of leukemia, such as chronic myeloid leukemia (CML). Pegaspargase is available in both injectable and oral forms. The injectable form is typically administered intravenously, while the oral form is taken as a pill. Some companies in the Pegaspargase market include Pfizer, Novartis, and Sanofi. Show Less Read more